One in 12 Americans have tried a GLP-1 drug, including me—I’ve been on one for six years. So it’s not exactly shocking that nearly every industry is scrambling to stake its claim. There are “GLP-1 support” supplements from Thorne, Sakara, and Cymbiotica; Ozempic menus popping up everywhere from downtown Manhattan to José Andrés restaurants in DC; even metabolic-tracking apps and electrolyte packs tailored to users navigating a slowed digestive tract.
Beauty hasn’t just joined the party—it’s carving out a new category. Some of the discourse has, candidly, veered into clickbait territory (see: Ozempic Vulva, Ozempic Earlobes), but there is actually a need for innovation around Ozempic Face, a zeitgeist-y catchall for gauntness and skin laxity that can often accompany large weight loss. Its effect on aesthetics is well measured. The American Academy of Plastic Surgery reports a 50 percent spike in fat-grafting procedures, and one in four surgeons anticipate that GLP-1 medications will drive a growing demand for non-surgical treatments like injectable fillers and skin-tightening procedures.
